DOAJ Open Access 2025

The excretion study of 4-(5-methyl-1,3,4-oxadiazole-2-yl)-benzenesulfonamide in rats

Alexander L. Khokhlov Ilya I. Yaichkov Anton A. Shetnev Mikhail K. Korsakov Nikita N. Volkhin

Abstrak

Introduction: The 4-(5-methyl-1,3,4-oxadiazole-2-yl)-benzenesulfonamide (ODASA) is a newcarbonic anhydrase II inhibitor for open-angle glaucoma treatment, but the excretion study of this compound has not been performed yet. Aim: Calculation of excretion parameters of ODASAand its metabolites in urine and feces in rats. Materials and Methods: The ODASA excretion was investigated on 6 Wistar rats. The 1% suspension of ODASA was instilled into each eye in a volume of 20μL (1.6 mg/kg). Excreta were collected using metabolic cages. Sampling of feces was performed every 24 h for 384 h after the administration. Urine was taken frequently in first day of experiment: 4 h, 8 h and 12 h after administration. Samples was stabilized and frozen (temperature <-70°C). Quantification of ODASA, 4-[5-(hydroxymethyl)-1,3,4-oxadiazole-2-yl]-benzenesulfonamide (M1), N-hydroxy-4-(5-methyl-1,3,4-oxadiazole-2-yl)-benzenesulfonamide (M2), 4-(5-methyl-1,3,4-oxadiazole-2-yl)-benzenesulfonic acid (M3) was carried out by HPLC-ESI-MS/MS. M2 was unstable in samples, and its content was calculated by summing the concentrations of M2 and its degradation product M3. Kinetex Phenyl Hexyl column (50*4.6 mm, 2.6 µm) was used for chromatographic separation. Results: The developed bioanalytical methods for rat excreta analysis were validated in the range of 10-10000 ppb for ODASA and M1, 1-1000 ppb – for M2, and 5-5000 ppb – for M3. Part of 16.29±1.60% of the active compound was eliminated in unchanged form, 80.27±1.68% – in the form of M1, and 3.43±0.33% – in form of M2 (М±SEM). The drug is mainly excreted by renal route: 14.22±1.43% in the form of ODASA, 69.90±1.80% – in the form of M1, and 1.88±0.24% – in the form of M2 (М±SEM). The highest rate of renal excretion of the studiedcompounds was observed in period of 8-12 hours after administration. The complete elimination of ODASA was achieved through 360 h after administration. Conclusion: Most part of ODASA is eliminated in the form of M1. The main route of excretion is renal. The use of validated bioanalytical methods guaranteed reliability of the obtained data.

Topik & Kata Kunci

Penulis (5)

A

Alexander L. Khokhlov

I

Ilya I. Yaichkov

A

Anton A. Shetnev

M

Mikhail K. Korsakov

N

Nikita N. Volkhin

Format Sitasi

Khokhlov, A.L., Yaichkov, I.I., Shetnev, A.A., Korsakov, M.K., Volkhin, N.N. (2025). The excretion study of 4-(5-methyl-1,3,4-oxadiazole-2-yl)-benzenesulfonamide in rats. https://doi.org/10.18413/rrpharmacology.11.524

Akses Cepat

Informasi Jurnal
Tahun Terbit
2025
Sumber Database
DOAJ
DOI
10.18413/rrpharmacology.11.524
Akses
Open Access ✓